Element Nutritional Sciences Inc.
ELNSF
Other OTC0.07
USD
-0.02
- -
ISIN
CA74290V1058
Return %
Stock
S&P500
1Y
-19.54
19.25
3Y
-82.37
65.11
5Y
-82.37
72.21
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Vito Sanzone
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 1100 Walkers Line Burlington ON Canada L7N 2G3
- IPO Date
- Oct 25, 2021
- Website
- elmtinc.com
- Similar Companies
- Business
- Element Nutritional Sciences Inc. (ELNSF) develops, manufactures, and markets innovative nutritional products focused on sports nutrition, health supplements, and functional foods. The company offers a portfolio of science-backed products including protein blends under the ELEVAR brand, electrolyte hydration formulas, amino acid supplements, and performance-enhancing bars; it also provides contract manufacturing services for custom nutritional formulations targeting athletes, fitness enthusiasts, and health-conscious consumers. Headquartered in Orlando, Florida, the company was founded in 2022 and operates primarily in North America with distribution through retail, e-commerce, and wholesale channels in the United States and Canada. Element Nutritional Sciences serves the competitive nutrition segment of the dietary supplement industry, emphasizing clinically studied ingredients for muscle recovery, energy support, and metabolic health. Its target markets include professional athletes, gym-goers, and wellness brands seeking premium, non-GMO, and gluten-free options. The company maintains research partnerships with universities to validate product efficacy and holds cGMP-certified facilities for production. In late 2024, Element Nutritional Sciences completed a reverse takeover transaction via a merger with a public shell company, enabling its listing on the OTCQB Venture Market under the ticker ELNSF and marking its transition to a publicly traded entity. This strategic move facilitated a C$11.5 million private placement financing in early 2025 to support production scaling and brand expansion. Additionally, the company launched its flagship ELEVAR protein line in Q3 2025, featuring novel leucine-enriched formulas, and announced a distribution alliance with major U.S. fitness retailers to broaden market penetration.
Element Nutritional Sciences to Report Record Revenue in Q1 2022
Element Nutritional Sciences to Report 108% Revenue Growth and Updates Operational Milestones